Novo Nordisk A/S (NVO) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Novo Nordisk A/s Class B.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.356 Good day and thank you for standing by. Welcome to the Q3 2025 Novo Nordisk Earnings 00:00:05.356 -- 00:00:09.841 Conference Call. At this time all participants are in a listen-only mode. 00:00:09.841 -- 00:00:13.345 After the speaker's presentation there'll be a question and answer session. 00:00:13.345 -- 00:00:18.049 To ask a question during the session you will need to press star 1 and 1 on your telephone. 00:00:18.049 -- 00:00:21.573 You will then hear an automated message advising your hand is raised. 00:00:21.573 -- 00:00:24.877 To withdraw your question please press star 1 and 1 again. 00:00:24.877 -- 00:00:28.651 Please be advised that today's conference is being recorded. 00:00:28.651 -- 00:00:32.236 I would now like to hand the conference over to your first speaker today, Jakob Rode, 00:00:32.236 -- 00:00:35.982 Head of Investor Relations. Please go ahead. 00:00:35.982 -- 00:00:40.889 Thank you. Welcome to this NOVA Nordisk earnings call for the first nine months of 2025. 00:00:40.889 -- 00:00:44.314 My name is Jakob Rode, and I'm the Head of Investor Relations. 00:00:44.314 -- 00:00:49.021 With me today, I have CEO of NOVA Nordisk, Mike Duster, Executive Vice President, Product 00:00:49.021 -- 00:00:52.967 and Portfolio Strategy, Ludwig Helfgott, Executive Vice President, U.S. 00:00:52.967 -- 00:00:57.899 Operations, Dave Maul, Executive Vice President Research and Development and Chief Scientific 00:00:57.899 -- 00:01:02.987 Officer Martin Holst-Lange and Chief Financial Officer Carsten Munkhausen. 00:01:02.987 -- 00:01:06.091 All speakers will be available for the Q&A session. 00:01:06.091 -- 00:01:10.277 Please note that the call is being webcasted live and a recording will be available on 00:01:10.277 -- 00:01:15.32...